Bavarian Nordic AS Aktie - BV3

Rendering Error

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

20,82

Gebot

20,72

Fragen

20,91

Volumen

557

20,36 Tagesbereich 20,98

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

1,626B

Handelsende

20,56

Handelsbeginn

20,49

Letzte Trade

20.98

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

78.097.834

Dividendenrendite

Kurs-Gewinn-Verhältnis

1,63

Gewinn pro Aktie (EPS)

12,65

Erlöse

5,72B

Nettogewinn

987,98M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.bavarian-nordic.com

Hauptsitz

Kvistgaard, Dnk

Gegründet

Bavarian Nordic AS is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker BV3. The last closing price for Bavarian Nordic AS was 20,56 €. Over the last year, Bavarian Nordic AS shares have traded in a share price range of 0,00 € to 0,00 €.

Bavarian Nordic AS currently has 78.097.834 shares in issue. The market capitalisation of Bavarian Nordic AS is 1,61 € billion. Bavarian Nordic AS has a price to earnings ratio (PE ratio) of 1.63.

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP) Recommendation...

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX:...

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today...

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S...

Bavarian Nordic A/S – Notice Convening Annual General Meeting

Bavarian Nordic A/S – Notice Convening Annual General Meeting COPENHAGEN, Denmark, March 12, 2025 – Pursuant to Articles 10-14 of the Articles of...

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older...

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

BV3 - Frequently Asked Questions (FAQ)

What is the current Bavarian Nordic AS share price?

The current share price of Bavarian Nordic AS is 20,82 €

How many Bavarian Nordic AS shares are in issue?

Bavarian Nordic AS has 78.097.834 shares in issue

What is the market cap of Bavarian Nordic AS?

The market capitalisation of Bavarian Nordic AS is EUR 1,61B

What is the 1 year trading range for Bavarian Nordic AS share price?

Bavarian Nordic AS has traded in the range of 0,00 € to 0,00 € during the past year

What is the PE ratio of Bavarian Nordic AS?

The price to earnings ratio of Bavarian Nordic AS is 1,63

What is the cash to sales ratio of Bavarian Nordic AS?

The cash to sales ratio of Bavarian Nordic AS is 0,28

What is the reporting currency for Bavarian Nordic AS?

Bavarian Nordic AS reports financial results in DKK

What is the latest annual turnover for Bavarian Nordic AS?

The latest annual turnover of Bavarian Nordic AS is DKK 5,72B

What is the latest annual profit for Bavarian Nordic AS?

The latest annual profit of Bavarian Nordic AS is DKK 987,98M

What is the registered address of Bavarian Nordic AS?

The registered address for Bavarian Nordic AS is HEJRESKOVVEJ 10A, KVISTGAARD, DK-3490

What is the Bavarian Nordic AS website address?

The website address for Bavarian Nordic AS is www.bavarian-nordic.com

Which industry sector does Bavarian Nordic AS operate in?

Bavarian Nordic AS operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
WW6Ww International Inc	0,3468 € (169,88%)	144,1k
OYM1Odyssey Marine Exploration Inc	1,39 € (82,89%)	120,38k
VW5Cannabist Company Holdings Inc	0,0643 € (78,61%)	153,41k
Z620Trillion Energy International Inc	0,0307 € (48,31%)	103,45k
K8DWellfield Technologies Inc	0,0142 € (47,92%)	500
A07Avance Gas Holding Ltd	0,27 € (-46,80%)	1,26M
3SHShunfeng International Clean Energy Limited	0,0014 € (-36,36%)	3k
SQRSaia Inc.	216,00 € (-30,77%)	528
L7C2Windfall Geotek Inc	0,008 € (-30,43%)	32,29k
3PJ1Golden Dory Resourses	0,02 € (-25,93%)	40k
DMLSayona Mining Limited	0,0113 € (4,63%)	2,52M
11LCanopy Growth Corporation	1,222 € (-6,86%)	2,31M
PF8European Lithium Limited	0,0314 € (3,29%)	2,18M
D7GNel ASA	0,1982 € (-1,49%)	2,15M
3CPXiaomi Corporation	5,459 € (-1,83%)	1,56M

Rendering Error

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bavarian Nordic AS (BV3)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Bavarian Nordic AS

BV3 Neueste Nachrichten

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine

Bavarian Nordic A/S – Notice Convening Annual General Meeting

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Bavarian Nordic Publishes Annual Report 2024

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine

BV3 - Frequently Asked Questions (FAQ)

Beweger

BV3 Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bavarian Nordic AS (BV3) Börsenkurse

Bavarian Nordic AS (BV3)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Bavarian Nordic AS

BV3 Neueste Nachrichten

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine

Bavarian Nordic A/S – Notice Convening Annual General Meeting

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Bavarian Nordic Publishes Annual Report 2024

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine

BV3 - Frequently Asked Questions (FAQ)

Beweger

BV3 Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich für ein Konto unter ADVFN

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE